| Name | Title | Contact Details |
|---|
Care New England Health System (CNE) and its member institutions—Butler Hospital, Women & Infants Hospital, Kent Hospital, Memorial Hospital, VNA of Care New England, The Providence Center and Care New England Wellness Center—are trusted organizations fueling the latest advances in medical research, attracting the nation`s top specialty-trained doctors, and honing renowned services and innovative programs to engage in the important discussions people need to have about their health. Backed by a broad range of services—primary care, surgery, cardiovascular care, oncology, psychiatry, behavioral health, newborn pediatrics and the full spectrum of women`s health services—CNE is reinventing the way health care is delivered, partnering with our patients to provide the best care possible while working to create a community of healthier people. To that end, we are committed to a culture of accountability, caring and teamwork. We called it ACT values. These values were not defined by senior management but through a comprehensive process with our employees who identified these values as tangible and important to the cohesiveness of the entire organization. They are embedded into everything we do, working with patients and their families, and with each other.
Holmes Lake Manor is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Long Island Occupational is a Port Jefferson, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
On-X Life Technologies is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.